Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • high-court

    Tag: High Court

    You Searched For "high-court"
    HC relief  to J&J: stays order directing co to pay Rs 230 crore on account of GST profiteering

    HC relief to J&J: stays order directing co to pay Rs 230 crore on account of GST profiteering

    Medical Dialogues Bureau5 March 2020 12:45 PM IST
    It also said that prima facie the methodology used by NAPA to arrive at its finding of profiteering was "flawed".
    PIL against Health Ministry notifying 8 medical devices as DRUGS, Delhi HC seeks Centre reply

    PIL against Health Ministry notifying 8 medical devices as DRUGS, Delhi HC seeks Centre reply

    Medical Dialogues Bureau30 Sept 2019 5:54 PM IST
    It was submitted that notifying blood monitoring devices, digital thermometers, nebulizers and glucometers as DRUGS will result in a substantial hike...
    Regulation of OTC drugs : CDSCO to soon amend Schedule K of Drugs and Cosmetics Act

    Regulation of OTC drugs : CDSCO to soon amend Schedule K of Drugs and Cosmetics Act

    Farhat Nasim21 Sept 2019 3:21 PM IST
    The Sub-Committee is of the opinion that there is an urgent need for defining the Over-the-Counter (OTC) drugs and to lay down specific provisions for...
    GSK Pharma sells 60 acres land in Thane to Oberoi Realty for Rs 890 crore

    GSK Pharma sells 60 acres land in Thane to Oberoi Realty for Rs 890 crore

    Medical Dialogues Bureau31 Aug 2019 12:54 PM IST
    Mumbai: Glaxo Smith Kline Pharmaceuticals (GSK) has divested around 60 acres of its lands at Thane in favour of Oberoi Realty for nearly Rs 890 crore...
    Regulation of E-Pharmacies: DTAB calls for finalization of rules to regulate online sale, distribution of drugs

    Regulation of E-Pharmacies: DTAB calls for finalization of rules to regulate online sale, distribution of drugs

    Medical Dialogues Bureau28 Aug 2019 5:04 PM IST
    New Delhi: In light of concerns raised in various forums, the Drugs Technical Advisory Board (DTAB) has recently recommended for finalization of the...
    Apixaban Patent: Natco gets HC relief for its upcoming medicine Apigat

    Apixaban Patent: Natco gets HC relief for its upcoming medicine Apigat

    Farhat Nasim26 July 2019 3:00 PM IST
    NEW DELHI: Days after ending a patent row over its cancer drug Regonat with Bayer, drugmaker, Natco Pharma is reported to have now been embroiled in a...
    Delhi HC restricts Lee Pharma from infringing copyright of Mankind Pharma

    Delhi HC restricts Lee Pharma from infringing copyright of Mankind Pharma

    Medical Dialogues Bureau21 July 2019 4:30 PM IST
    Justice Prathiba M Singh said considering the evidence and the content of the website of Lee Pharmaceuticals of Lee House being identical, a permanent...
    Delhi HC directs cashless service to all hospitals: GIPSA stayed on Ophthalmological Society petition

    Delhi HC directs cashless service to all hospitals: GIPSA stayed on Ophthalmological Society petition

    Farhat Nasim13 Jun 2019 3:23 PM IST
    New Delhi: Breaking the alleged cartel of public sector general insurance companies when it comes to mediclaim treatment, the Delhi High court has...
    Delhi High Court directs RSSB chief Dhillon, family to undertake Singh brothers dues to Daiichi

    Delhi High Court directs RSSB chief Dhillon, family to undertake Singh brothers dues to Daiichi

    Farhat Nasim11 Jun 2019 3:31 PM IST
    New Delhi: Bringing in a third party, the Delhi High Court has directed Radha Soami Satsang Beas (RSSB) chief Gurinder Singh Dhillon and his family...
    Biocon, Lupin, Wockhardt, Cadila Healthcare lose Insurance Battle in Delhi High Court

    Biocon, Lupin, Wockhardt, Cadila Healthcare lose Insurance Battle in Delhi High Court

    Meghna A Singhania3 May 2019 1:50 PM IST
    Mumbai:In a court setback to many big drugmakers in India, a petition filed by pharma majors including Biocon, Wockhardt, Lupin and Cadila Healthcare...
    Setback to Sanofi: Court refuses to quash corruption case, directs CBI to continue inquiry

    Setback to Sanofi: Court refuses to quash corruption case, directs CBI to continue inquiry

    Meghna A Singhania18 Feb 2019 6:03 PM IST
    It was alleged that BARC employees reportedly influenced the selection of tenders for the purchase of drugs. They illegally favoured Sanofi and...
    Nagpur : Sun Pharma employees call it  strike

    Nagpur : Sun Pharma employees call it strike

    Geeta Sharma Sharma28 Jun 2016 2:00 PM IST
    Nagpur:A group of Sun Pharma employees are on a strike against alleged illegal transfer of 54 employees and withholding of salary and expenses of...
    Next

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok